Wk 7 Cancer and Immunology Flashcards
What 3 processes result in immunoediting?
- Elimination = Immunosurveillance: elimination of tumors by the immune system. When not successful, progression occurs.
- Equilibrium = Darwinian selection of tumor variants
- Escape = Ultimate consequence of “equilibrium” phase and appearance of clinically
apparent tumors
What happens in the elimination process?
=subclinical
1. Tumors grow invasively, require blood supply -> produce stromogenic and angiogenic proteins
2. inflammation induced. Innate cells recruited (NKT, NK, gamma….T cells, macrophages, dendritic cells, CD8+ T cell most Important!)
3. IFN gamma produced, causing some tumor cell death, recruitment and activation of NK cells and macrophages
4. Tumor cell debris taken up by DC’s – home to lymph nodes
5. Initiation of adaptive immune response
What kids of immune evasion occur?
- *Loss of MHC or antigen expression
- *T cell expression of negative costimulatory molecules: CTLA-4, PD-1
*Tregs: IL-10, TGF-beta
*Myeloid-derived suppressor cells (MDSC)
*Loss of inflammatory (M1) macrophages
*Clinically observable malignant disease occurs
Tumors can be hypoxic
Why do tumors escape control by the immune system?
- Loss of tumor antigens or MHC
- Active immunosuppression: Tregs
- Non-protective immune responses
What viruses are good at downregulating MHC class I?
Herpesviruses
What happens to tumor cells when there is loss of expression of HLA class I proteins?
They are susceptible to NK cells, but NKs are often insufficient on their own to suppress tumor growth
What IS cells are found in many human cancers?
Tregs
*Associated with decreased survival
*Induces cycle of immune suppression
*Directly suppress activated T cells
*Convert activated APCs into suppressive APCs
*IL-10, TGF beta
Diagram of tumors and the non-protective immune response they induce
What are 5 things we can do to promote anti-tumor therapy?
- Cancer vaccines
- High Dose IL-2
- Transfer of tumor-specific T cells
- Adoptive cell therapy (ACT)
- Chimeric antigen receptor (CAR) T cells - Checkpoint blockade (anti-CTLA-4, anti-PD-1)
- Monoclonal antibodies
What is adoptice cellular therapy (ACT)?
- In vitro expansion of tumor antigen specific CTL
- Development of T cell lines that are tumor-specific
- Cloning of high affinity TCRs, gene transfer into effector CTL
- Injection back into patient
- Very personalized, very expensive, high expertise required
What are CAR T cells?
=chimeric antigen receptor T cells
-can be used to target tumors like B cell lymphomas expressing CD19 (overexpressed in certain B cell lymphomas)
70-90% complete response rate for B-ALL
What does it mean to block checkpoints?
Remove (block) pathways that inhibit tumor immunity. PD-1 and CTLA-4 inhibit TCR and CD28 signaling
1. anti-CTLA4 (ipilimumab)
2. anti-PD-1 (nivolumab, pembrolizumab)
3. anti-PDL1 (Atezolizumab, Avelumab, Durvalumab)